Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Finally Gets An Administrator; Berwick In Until Late 2011, At Least

Executive Summary

Before he has to face a congressional confirmation process, incoming CMS Administrator Donald Berwick will have a year and a half to demonstrate he is, as the Obama administration says, "supremely and uniquely qualified" to implement major health care reforms while overseeing the day-to-day operations of the Centers for Medicare and Medicaid Services

You may also be interested in...



Berwick Highlights Part D Gap Discounts In Defending Reform Law Before Ways And Means Committee

In his first hearing before a House committee, CMS chief Donald Berwick emphasized the importance of the Medicare Part D coverage gap discount program in his defense of the Affordable Care Act.

Berwick Wants Strong Public/Private Partnership To Help CMS Improve Care

CMS Administrator Don Berwick makes first public appearance before members of Congress at Nov. 17 Senate Finance Committee hearing.

Berwick’s Call To Action: CMS Needs Industry Partners With “Authentic” Aims

The Centers for Medicare and Medicaid Services is seeking stakeholder collaboration to implement health care reforms but will only work with partners dedicated to true change, CMS Administrator Donald Berwick asserted at the America’s Health Insurance Plans Medicare conference in Washington, D.C., Sept. 13.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052412

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel